Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tsao, Ming S."'
Autor:
Lindeman NI; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: nlindeman@partners.org., Cagle PT; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas., Aisner DL; Department of Pathology, University of Colorado School of Medicine, Denver, New York., Arcila ME; Diagnostic and Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Beasley MB; Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York., Bernicker EH; Cancer Center, Houston Methodist Hospital, Houston, Texas., Colasacco C; Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois., Dacic S; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania., Hirsch FR; Department of Medicine and Pathology, University of Colorado, Denver, New York., Kerr K; Department of Pathology, University of Aberdeen, Aberdeen, Scotland., Kwiatkowski DJ; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Ladanyi M; Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, New York., Nowak JA; Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York., Sholl L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Temple-Smolkin R; Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland., Solomon B; Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia., Souter LH; Private Practice, Wellanport, Ontario, Canada., Thunnissen E; Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands., Tsao MS; Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada., Ventura CB; Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois., Wynes MW; Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado., Yatabe Y; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2018 Mar; Vol. 13 (3), pp. 323-358. Date of Electronic Publication: 2018 Jan 25.
Autor:
Lindeman NI; From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada., Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-Smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y
Publikováno v:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2018 Mar; Vol. 142 (3), pp. 321-346. Date of Electronic Publication: 2018 Jan 22.
Autor:
Lindeman NI; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: nlindeman@partners.org., Cagle PT; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas., Aisner DL; Department of Pathology, University of Colorado School of Medicine, Denver, Colorado., Arcila ME; Diagnostic and Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Beasley MB; Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York., Bernicker EH; Cancer Research Program, Houston Methodist Research Institute, Houston, Texas., Colasacco C; Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois., Dacic S; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania., Hirsch FR; Department of Medicine and Pathology, University of Colorado, Denver, Colorado., Kerr K; Department of Pathology, University of Aberdeen, Aberdeen, Scotland., Kwiatkowski DJ; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Ladanyi M; Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, New York., Nowak JA; Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York., Sholl L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Temple-Smolkin R; Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland., Solomon B; Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia., Souter LH, Thunnissen E; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Tsao MS; Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada., Ventura CB; Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois., Wynes MW; Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado., Yatabe Y; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2018 Mar; Vol. 20 (2), pp. 129-159. Date of Electronic Publication: 2018 Jan 23.